企業プロフィール
Tyra Biosciences 株価・ニュース・カタリスト
- ティッカー:
- TYRA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
26.05 USD (+1.40%)
終値
最終更新: 2026年8月21日
1.7B USD
時価総額
株価変動の要因
As of Aug 21, 2026, TYRA closed up 1.40% at $26.05. No new same-company headline was identified in the current news window.
企業概要
事業概要
Tyra Biosciences is a precision-oncology company focused on FGFR and related kinase biology. The company is trying to build a targeted-therapy franchise around genetically defined cancers.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Tyra sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical proof, molecule selectivity, and the possibility of creating a differentiated kinase platform.
バイオ業界での位置付け
Tyra is a high-beta oncology name whose valuation is highly sensitive to early clinical data.
今後のカタリスト
- Tyra Biosciences's catalyst is TYRA-300, with FGFR3-driven bladder-cancer data and related FGFR updates likely to matter most. The market will care about whether the precision-oncology story stays differentiated.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。